|
FY2016
12 months to Dec 31, 2016
|
FY2015
12 months to Dec 31, 2015
|
FY2014
12 months to Dec 31, 2014
|
FY2013
12 months to Dec 31, 2013
|
FY2012
12 months to Dec 31, 2012
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net loss | |||||
| Income (loss) from discontinued operations | |||||
| Loss from continuing operations | |||||
| Adjustments to reconcile net loss from continuing operations to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash benefit from income taxes | |||||
| Gain on sale of available for sale securities | |||||
| Net amortization of premiums on marketable securities | |||||
| Amortization of debt discount and loan fees | |||||
| Amortization of loan fees | |||||
| Issuance of common stock in connection with professional services rendered | |||||
| Warrant expense related to vesting of ADM Warrant | |||||
| Debt conversion expense | |||||
| Provision for doubtful accounts | |||||
| Restructuring charges | |||||
| Stock-based compensation expense | |||||
| Loss from equity method investments | |||||
| Revaluation of warrant liability | |||||
| Gain from change in fair value of derivative liabilities | |||||
| Loss on retirement of fixed assets | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Unbilled revenues | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other current and long-term liabilities | |||||
| Net cash used in operating activities — continuing operations | |||||
| Net cash used in operating activities — discontinued operations | |||||
| Net cash used in operating activities | |||||
| Investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds received from the sale of equipment | |||||
| Purchases of marketable securities | |||||
| Proceeds from maturities of marketable securities | |||||
| Proceeds from sales of marketable securities | |||||
| Capital contributions in unconsolidated joint ventures | |||||
| Capitalized interest related to unconsolidated joint venture | |||||
| Restricted certificates of deposit | |||||
| Net cash provided by (used in) investing activities — continuing operations | |||||
| Net cash provided by (used in) investing activities — discontinued operations | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities: | |||||
| Repayments under loan agreements | |||||
| Proceeds from the issuance of senior subordinated convertible notes, net of discount | |||||
| Proceeds from the issuance of common stock | |||||
| Proceeds from issuance of common stock, pursuant to ESPP | |||||
| Early exercise of stock options subject to repurchase | |||||
| Proceeds from borrowings under loan agreements | |||||
| Proceeds from issuance of preferred stock, net of offering costs | |||||
| Payment for loan costs and fees | |||||
| Proceeds from issuance of common stock in a public offering, net of underwriting discounts and commission | |||||
| Cash settlement of vested restricted stock units | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) of cash and cash equivalents | |||||
| Cash and cash equivalents—beginning of period | |||||
| Cash and cash equivalents—end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid in cash, net of capitalized interest | |||||
| Income taxes paid in cash | |||||
| Supplemental disclosure of noncash investing and financing activities: | |||||
| Purchase of property, plant and equipment in accounts payable and accrued liabilities | |||||
| Debt issue costs in accounts payable and accrued liabilities | |||||
| Change in unrealized gain (loss) on marketable securities | |||||
| Foreign currency translation adjustment related to unconsolidated joint venture | |||||
| Reclassification of warrant liability to additional paid-in capital | |||||
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | |||||
| Warrant issued for investment in unconsolidated joint venture | |||||
| Capital contribution to unconsolidated joint venture settled with reduction of receivable | |||||
| Common stock issued in lieu of cash bonus | |||||
| Common stock issued to Archer-Daniels-Midlands Company pursuant to termination agreement | |||||
| Non-cash issuance of common stock options for offering costs | |||||
| Convertible debt exchanged | |||||
| Early conversion on Senior Convertible Notes settled in common stock | |||||
| Conversion of Senior Convertible Notes pursuant to inducement settled in common stock | |||||
| Issuance of common stock | |||||
| Common Stock | |||||
| Convertible Preferred Stock | |||||
Loading...